{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:11:20Z","timestamp":1790140280244,"version":"4.0.1"},"reference-count":35,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The influence of metabolic syndrome (MetS) on long-term prognosis of patients\n                    with myocardial infarction (MI), the most severe type of coronary artery\n                    disease, remains not fully determined. This systematic review and meta-analysis\n                    were conducted to investigate the association between MetS and long-term\n                    clinical outcomes of patients with MI. A systematic search of Medline, Web of\n                    Science, and Embase databases from inception to June 25, 2023, was conducted to\n                    obtain eligible studies. Only studies with follow-up duration for at least one\n                    year were considered. A random-effects model was utilized to pool the results,\n                    accounting for heterogeneity. Ten observational studies were included, which\n                    included 33 197 patients with MI. Among them, 17 244 (51.9%) were with\n                    MetS at baseline. During a follow-up duration of 12 to 48 months (mean: 22.5\n                    months), patients with MetS were associated with higher incidence of major\n                    adverse cardiovascular events [risk ratio (RR): 1.35. 95% confidence\n                    interval (CI): 1.19 to 1.54, p&lt;0.001; I2=64%] and\n                    all-cause deaths (RR: 1.34, 95% CI: 1.18 to 1.52, p&lt;0.001;\n                    I2=23%), as compared to those without MetS at baseline. Subgroup\n                    analyses showed that the results were not significantly affected by study\n                    characteristics such as study country, design, type of MI, mean age of the\n                    patients, treatment with percutaneous coronary intervention, follow-up\n                    durations, or study quality scores (p for subgroup difference all&gt;0.05).\n                    In patients with MI, MetS may be a risk factor of poor long-term prognosis.<\/jats:p>","DOI":"10.1055\/a-2196-3764","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:08:43Z","timestamp":1701907723000},"page":"435-444","source":"Crossref","is-referenced-by-count":5,"title":["Influence of Metabolic Syndrome on the Long-Term Prognosis of\n                    Patients with Myocardial Infarction: A Meta-Analysis"],"prefix":"10.1055","volume":"56","author":[{"given":"Tianfeng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhuji Affiliated Hospital of Wenzhou Medical\n                    University, Zhuji, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhewei","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhuji Affiliated Hospital of Wenzhou Medical\n                    University, Zhuji, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caizhen","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhuji Affiliated Hospital of Wenzhou Medical\n                    University, Zhuji, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"ref1","first-page":"e93","article-title":"Heart disease and stroke statistics-2023 update: a report From the American\n                    heart association","volume":"147","author":"C W Tsao","year":"2023","journal-title":"Circulation"},{"key":"ref2","first-page":"e9349","article-title":"Global epidemiology of ischemic heart disease: results from the Global Burden of\n                    Disease Study","volume":"12","author":"M A Khan","year":"2020","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12928-021-00829-9","article-title":"CVIT expert consensus document on primary percutaneous coronary intervention\n                    (PCI) for acute myocardial infarction (AMI) update 2022","volume":"37","author":"Y Ozaki","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","author":"M C Bahit","year":"2018","journal-title":"JACC Heart Fail"},{"key":"ref5","first-page":"118","volume-title":"Evolution of the prognosis of acute myocardial infarction","author":"G Oristrell","year":"2023"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"R H Eckel","year":"2005","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/nu15030640","article-title":"New advances in metabolic syndrome, from prevention to treatment: the role of\n                    diet and food","volume":"15","author":"D Ambroselli","year":"2023","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"M G Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and\n                    meta-analysis","volume":"56","author":"S Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00281-017-0666-5","article-title":"Hemostasis, endothelial stress, inflammation, and the metabolic syndrome","volume":"40","author":"G Grandl","year":"2018","journal-title":"Semin Immunopathol"},{"key":"ref11","first-page":"1","article-title":"Metabolic syndrome and insulin resistance: underlying causes and modification by\n                    exercise training","volume":"3","author":"C K Roberts","year":"2013","journal-title":"Compr Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.3390\/ijms24097898","article-title":"Mechanisms of oxidative stress in metabolic syndrome","volume":"24","author":"S K Masenga","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"704145","DOI":"10.3389\/fcvm.2021.704145","article-title":"Impact of metabolic syndrome and its components on prognosis in patients with\n                    cardiovascular diseases: a meta-analysis","volume":"8","author":"X Li","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/a-1946-4823","article-title":"Association of metabolic syndrome with adverse outcomes in patients with stable\n                    coronary artery disease: a meta-analysis","volume":"55","author":"Y Su","year":"2023","journal-title":"Horm Metab Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41440-022-00951-y","article-title":"Impact of risk factors related to metabolic syndrome on acute myocardial\n                    infarction in younger patients","volume":"45","author":"T Hasebe","year":"2022","journal-title":"Hypertens Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for\n                    reporting systematic reviews","volume":"372","author":"M J Page","year":"2021","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jacc.2005.03.062","article-title":"Metabolic syndrome and risk of cardiovascular events after myocardial\n                    infarction","volume":"46","author":"G Levantesi","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1253\/circj.72.415","article-title":"Impact of metabolic syndrome on the long-term survival of patients with acute\n                    myocardial infarction: potential association with C-reactive protein","volume":"72","author":"M Takeno","year":"2008","journal-title":"Circ J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MCA.0b013e3283472a87","article-title":"Admission with metabolic disorder is a useful predictor of the 1-year prognosis\n                    for patients with unstable angina, but not for patients with acute myocardial\n                    infarction: east-Osaka acute coronary syndrome registry","volume":"22","author":"S Hoshida","year":"2011","journal-title":"Coron Artery Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.metabol.2012.11.002","article-title":"Association of metabolic syndrome and renal insufficiency with clinical outcome\n                    in acute myocardial infarction","volume":"62","author":"C S Kim","year":"2013","journal-title":"Metabolism"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.amjcard.2018.03.366","article-title":"Effect of the metabolic syndrome on outcomes in patients aged<50 years\n                    versus>50 years with acute myocardial infarction","volume":"122","author":"I Kim","year":"2018","journal-title":"Am J Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jjcc.2018.03.010","article-title":"Influence of obesity and metabolic syndrome on clinical outcomes of ST-segment\n                    elevation myocardial infarction in men undergoing primary percutaneous coronary\n                    intervention","volume":"72","author":"S H Lee","year":"2018","journal-title":"J Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/00015385.2018.1424599","article-title":"Predictive value of metabolic syndrome definitions in patients with myocardial\n                    infarction with ST segment elevation \u2013 are they all the same?","volume":"73","author":"M B Lovic","year":"2018","journal-title":"Acta Cardiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.numecd.2022.01.007","article-title":"Metabolic syndrome and the risk of adverse cardiovascular events in patients\n                    with myocardial infarction with non-obstructive coronary arteries","volume":"32","author":"F A Abdu","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"920470","DOI":"10.3389\/fendo.2022.920470","article-title":"Impact of metabolic syndrome and its components on clinical severity and\n                    long-term prognosis in patients with premature myocardial infarction","volume":"13","author":"J Gao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"912999","DOI":"10.3389\/fcvm.2022.912999","article-title":"Prognostic value of metabolic syndrome in patients with non-ST elevated\n                    myocardial infarction undergoing percutaneous coronary intervention","volume":"9","author":"L H Zhao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/a-1381-8245","article-title":"Association between metabolic syndrome and all-cause mortality in patients with\n                    acute coronary syndrome: a meta-analysis","volume":"53","author":"Y Yang","year":"2021","journal-title":"Horm Metab Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2004.03.042","article-title":"Impact of obesity on long-term prognosis following acute myocardial\n                    infarction","volume":"98","author":"C Kragelund","year":"2005","journal-title":"Int J Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12933-022-01550-4","article-title":"Short and long-term prognosis of admission hyperglycemia in patients with and\n                    without diabetes after acute myocardial infarction: a retrospective cohort\n                    study","volume":"21","author":"H Upur","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jdi.13468","article-title":"Admission hyperglycemia as an independent predictor of long-term prognosis in\n                    acute myocardial infarction patients without diabetes: a retrospective\n                    study","volume":"12","author":"C Y Cui","year":"2021","journal-title":"J Diabetes Investig"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/ATVBAHA.119.312336","article-title":"Elevated serum non-HDL (high-density lipoprotein) cholesterol and triglyceride\n                    levels as residual risks for myocardial infarction recurrence under statin\n                    treatment","volume":"39","author":"K Suzuki","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.amjcard.2009.02.048","article-title":"Meta-analysis of adverse cardiovascular outcomes associated with antecedent\n                    hypertension after myocardial infarction","volume":"104","author":"G Chen","year":"2009","journal-title":"Am J Cardiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00059-020-04918-y","article-title":"Poor recovery of cardiac function in myocardial infarction patients with\n                    metabolic syndrome and microalbuminuria","volume":"46","author":"L Jin","year":"2021","journal-title":"Herz"},{"key":"ref36","first-page":"633","article-title":"Metabolic syndrome is a risk factor for development of heart failure in acute\n                    myocardial infarction","volume":"21","author":"M A Bari","year":"2012","journal-title":"Mymensingh Med J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S2213-8587(22)00043-2","article-title":"Metabolic risk factors and effect of alirocumab on cardiovascular events after\n                    acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised\n                    controlled trial","volume":"10","author":"P Ostadal","year":"2022","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2196-3764.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:33:44Z","timestamp":1730802824000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2196-3764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":35,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2024,5,27]]},"published-print":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2196-3764","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}